982 related articles for article (PubMed ID: 15948975)
1. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
2. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
3. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
4. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
Schechter NM; Brass LF; Lavker RM; Jensen PJ
J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
[TBL] [Abstract][Full Text] [Related]
5. Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds.
Huttunen M; Aalto ML; Harvima RJ; Horsmanheimo M; Harvima IT
Exp Dermatol; 2000 Aug; 9(4):258-65. PubMed ID: 10949547
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
[TBL] [Abstract][Full Text] [Related]
7. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
Li L; Meng XW; Krilis SA
J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
[TBL] [Abstract][Full Text] [Related]
8. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
He SH; Chen P; Chen HQ
Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
He SH; Chen HQ; Zheng J
Acta Pharmacol Sin; 2004 Dec; 25(12):1677-84. PubMed ID: 15569415
[TBL] [Abstract][Full Text] [Related]
10. In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy.
Beil WJ; Pammer J
Histochem Cell Biol; 2001 Dec; 116(6):483-93. PubMed ID: 11810190
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction.
Xia HZ; Kepley CL; Sakai K; Chelliah J; Irani AM; Schwartz LB
J Immunol; 1995 May; 154(10):5472-80. PubMed ID: 7730649
[TBL] [Abstract][Full Text] [Related]
12. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
Diaconu NC; Rummukainen J; Naukkarinen A; Mättö M; Harvima RJ; Pelkonen J; Harvima IT
Arch Dermatol Res; 2011 Sep; 303(7):499-512. PubMed ID: 21274549
[TBL] [Abstract][Full Text] [Related]
13. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
Goldstein SM; Leong J; Schwartz LB; Cooke D
J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
[TBL] [Abstract][Full Text] [Related]
14. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT
Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
[TBL] [Abstract][Full Text] [Related]
15. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.
Xia HZ; Du Z; Craig S; Klisch G; Noben-Trauth N; Kochan JP; Huff TH; Irani AM; Schwartz LB
J Immunol; 1997 Sep; 159(6):2911-21. PubMed ID: 9300715
[TBL] [Abstract][Full Text] [Related]
17. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
Lohi J; Harvima I; Keski-Oja J
J Cell Biochem; 1992 Dec; 50(4):337-49. PubMed ID: 1469068
[TBL] [Abstract][Full Text] [Related]
18. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
[TBL] [Abstract][Full Text] [Related]
19. Regulation of chymase production in human mast cell progenitors.
Ahn K; Takai S; Pawankar R; Kuramasu A; Ohtsu H; Kempuraj D; Tomita H; Iida M; Matsumoto K; Akasawa A; Miyazaki M; Saito H
J Allergy Clin Immunol; 2000 Aug; 106(2):321-8. PubMed ID: 10932077
[TBL] [Abstract][Full Text] [Related]
20. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]